AMSTERDAM, the Netherlands—For hemodynamically stable patients with STEMI and multivessel coronary artery disease, those who receive immediate complete revascularization fare just as well as those who ...

Intervening on significant nonculprit lesions in addition to the culprit lesion in patients with STEMI and multivessel PCI improves hard clinical outcomes, an updated meta-analysis shows. And a ...

Dual antiplatelet therapy (DAPT) consisting of aspirin plus a P2Y 12 inhibitor has been the standard of care to prevent thrombotic events in patients with acute coronary syndrome (ACS) undergoing ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Primary PCI should continue to be the standard of care ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHILADELPHIA -- ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Antiplatelet therapy with ticagrelor after primary PCI ...

The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer-reviewed. Various P2Y 12 inhibitors have different efficacies and bleeding risks, and ...

Dual antiplatelet therapy with a thienopyridine in combination with aspirin for 1 to 6 months after stenting has been recommended by the manufacturers to reduce ischemic cardiovascular events and ...

Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute coronary syndromes (ACS). Frequently characterized by older patients and more ...

Istanbul, Turkey – 20 October 2012: Coronary angioplasty improves survival in all patients with out of hospital cardiac arrest, according to research presented at the Acute Cardiac Care Congress 2012.